NEONATAL SEIZURES - PowerPoint PPT Presentation

About This Presentation
Title:

NEONATAL SEIZURES

Description:

NEONATAL SEIZURES Maria Theresa M. Villanos, MD PL-2 Laboratory Studies to Evaluate Neonatal Seizures Indicated Complete blood count, differential, platelet count ... – PowerPoint PPT presentation

Number of Views:913
Avg rating:3.0/5.0
Slides: 56
Provided by: exuteroFi
Category:

less

Transcript and Presenter's Notes

Title: NEONATAL SEIZURES


1
NEONATAL SEIZURES
  • Maria Theresa M. Villanos, MD
  • PL-2

2
Definition
  • A stereotypic, paroxysmal spell of altered
    neurologic function
  • (behavior, motor,and/or autonomic function)

3
Definition
  • Neonatal period limited to
  • - first 28 days for term infants
  • - 44 weeks gestational age for
  • pre-term

4
Frequency
  • In US incidence has not been established
    clearly
  • Estimated frequency of 80-120 per 100,000
    neonates/year
  • 1-51000 live births

5
Frequency
  • 0.5 incidence -National Collaborative
  • Perinatal Project( population-based study on
  • 54,000 FT and PT infants)
  • 0.23 incidence- Scher, et al
  • (population of 41,00 infants)
  • Incidence of seizures higher in the neonatal
  • period than in any other age group

6
Why do neonatal seizures have such unusual
presentations?
  • Immature CNS cannot sustain a
    synchronized, well orchestrated generalized
    seizure

7
  • Perinatal Anatomical and Physiological Features
    of Importance in Determining Neonatal Seizure
    Phenomena
  • ANATOMICAL
  • Neurite outgrowthdendritic and axonal
    ramificationsin
  • process
  • Synaptogenesis not complete
  • Deficient myelination in cortical efferent
    systems

Volpe JJ.Neonatal Seizures Neurology
of the Newborn.4th ed.
8
  • Perinatal Anatomical and Physiological Features
  • of Importance in Determining Neonatal Seizure
    Phenomena
  • PHYSIOLOGICAL
  • In limbic and neocortical regionsexcitatory
    synapses develop
  • before inhibitory synapses (?
    N-methyl-D-aspartate receptor
  • activity, gamma-aminobutyric acid excitatory)
  • Immature hippocampal and cortical neurons more
    susceptible to
  • seizure activity than mature neurons
  • Deficient development of substantia nigra system
    for inhibition of
  • seizures
  • Impaired propagation of electrical seizures, and
    synchronous
  • discharges recorded from surface
    electroencephalogram may
  • not correlate with behavioral seizure phenomena
  • __________________________________________________
    ____________________

Volpe JJ.Neonatal Seizures.InNeurology of the
Newborn.4th ed.
9
  • Probable Mechanisms of Some Neonatal Seizures
  • PROBABLE MECHANISM
    DISORDER
  • Failure of Na -K pump secondary to
    Hypoxemia, ischemia,
  • ? adenosine triphosphate
    and hypoglycemia
  • Excess of excitatory neurotransmitter
  • (eg.glutamic acidexcessive excitation)
    Hypoxemia, ischemia

  • and
    hypoglycemia
  • Deficit of inhibitory neurotransmitter
    Pyridoxine dependency
  • (i.e., relative excess of excitatory
  • neurotransmitter)
  • Membrane alteration ? Na
    Hypocalcemia and
  • Permeability
    hypomagnesemia
  • __________________________________________________
    _______________
  • Volpe JJ.Neonatal SeizuresNeurology of the
    Newborn.4th ed.

10
Classification of Neonatal Seizures
  • Clinical
  • Electroencephalographic

11
Classification
  • I. Clinical Seizure
  • Subtle
  • Tonic
  • Clonic
  • Myoclonic

12
Classification
  • II. Electroencephalographic seizure
  • Epileptic
  • Non-epileptic

13
Clinical Classification
  • 1. Subtle
  • More in preterm than in term
  • Eye deviation (term)
  • Blinking, fixed stare (preterm)
  • Repetitive mouth and tongue movements
  • Apnea
  • Pedaling and tonic posturing of limbs

14
Clinical Classification
  • 2. Tonic
  • Primarily in Preterm
  • May be focal or generalized
  • Sustained extension of the upper and
  • lower limbs (mimics decerebrate posturing)
  • Sustained flexion of upper with extension of
  • lower limbs (mimics decorticate posturing)
  • Signals severe ICH in preterm infants

15
Clinical Classification
  • 3. Clonic
  • Primarily in term
  • Focal or multifocal
  • Clonic limb movements(synchronous or
  • asynchronous, localized or often with no
    anatomic order of progression)
  • Consciousness may be preserved
  • Signals focal cerebral injury

16
Clinical Classification
  • 4. Myoclonic
  • Rare
  • Focal, multifocal or generalized
  • Lightning-like jerks of extremities
  • (upper gt lower)

17
Electroencephalographic seizure
  • I. Epileptic
  • Consistently associated with electro-cortical
    seizure activity on the EEG
  • Cannot be provoked by tactile stimulation
  • Cannot be suppressed by restraint of involved
    limb or repositioning of the infant
  • Related to hyper synchronous discharges of a
    critical mass of neuron

18
Electroencephalographic seizures
  • II. Non-epileptic
  • No electro-cortical signature
  • Provoked by stimulation
  • Suppressed by restraint or repositioning
  • Brainstem release phenomena (reflex)

19
  • Classification of Neonatal Seizures

  • ELECTROENCEPHALOGRAPHIC SEIZURE
  • CLINICAL SEIZURE COMMON
    UNCOMMON
  • Subtle
  • Clonic
  • Focal
  • Multifocal
  • Tonic
  • Focal
  • Generalized
  • Myoclonic
  • Focal, multifocal
  • Generalized
  • --------------------------------------------------
    --------------------------------------------------
    -----------
  • Only specific varieties of subtle seizures are
    commonly associate with simultaneous

20
Does absence of EEG seizure activity indicate
that a clinical seizure is non- epileptic?
  • Certain clinical seizures in the human newborn
    originate from electrical seizures in deep
    cerebral structures (limbic regions), or in
    diencephalic, or brain stem structures and
    thereby are either not detected by
    surface-recorded EEG or inconsistently propagated
    to the surface

21
Surface EEG-Silent Seizure
  • Can surface EEG-silent seizure in the newborn
    result to brain injury?
  • Can this be eliminated by conventional
    anticonvulsant therapy?
  • Further investigation needed

22
  • Jitteriness Versus Seizure
  • CLINICAL FEATURE JITTERINESS SEIZURE
  • Abnormality of gaze or eye O
  • movement
  • Movements exquisitely stimulus
    O
  • sensitive
  • Predominant movement Tremor
    Clonic jerking
  • Movements cease with passive
    O
  • flexion
  • Autonomic changes O
  • --------------------------------------------------
    --------------------------------------------------
    --------------

23
  • Normal Neonatal Motor Activity Commonly Mistaken
    for Seizure Activity
  • AWAKE OR DROWSY
  • Roving, sometimes dysconjugate eye movements,
    with
  • occasional nonsustained nystagmoid
  • jerks at the extremes of horizontal movement
    (contrast with fixed, tonic horizontal deviation
    of eyes with or without jerkingcharacteristic of
    subtle seizure
  • Sucking, puckering movements not accompanied by
    ocular fixation or deviation
  • SLEEP
  • Fragmentary myoclonic jerksmay be multiple
  • Isolated, generalized myoclonic jerk as infant
    wakes from sleep

Volpe JJ.Neonatal SeizuresNeurology of the
Newborn.4th ed.
24
Etiology
  • It is critical to recognize neonatal seizures, to
    determine their etiology, and to treat them for
    three major reasons
  • 1. Seizures are usually related to significant
    illness, sometimes requiring specific therapy

25
Etiology
  • 2.Neonatal seizures may interfere with important
    supportive measures, such as alimentation and
    assisted respirations for associated disorders.
  • 3.Experimental data give some reason for concern
    that under certain circumstances the seizure per
    se may be a cause of brain injury.

26
Etiology
  • Clinical history provides important clue
  • Family history may suggest genetic syndrome
  • Many of these syndromes are benign
  • In the absence of other etiologies, family
    history of seizures may suggest good prognosis

27
Etiology
  • Pregnancy history is important
  • Search for history that supports TORCH infections
  • History of fetal distress, preeclampsia or
    maternal infections

28
Etiology
  • Delivery history
  • Type of delivery and antecedent events
  • Apgar scores offer some guidance
  • Low Apgar score without the need for
    resuscitation and subsequent neonatal intensive
    care is unlikely to be associated with neonatal
    seizures

29
Etiology
  • Postnatal history
  • Neonatal seizures in infants without uneventful
    antenatal history and delivery may result from
    postnatal cause
  • Tremulousness may be secondary to drug withdrawal
    or hypocalcemia
  • Temperature and blood pressure instability may
    suggest infection

30

Comparison of prominent etiologic diagnoses of
seizures in the newborn period. (Data modified
from Mizrahi and Kellaway, 1987 Rose and
Lombroso, 1970)
Fanaroff A, Martin R.Neonatal seizures.
InNeonatal and Perinatal Medicine, Diseases of
the Fetus and Infant,6th ed.
31
  • Major Etiologies of Neonatal Seizures in Relation
    to Time of
  • Seizure Onset and Relative Frequency

  • TIME OF ONSET RELATIVE FREQUENCY
  • 0-3 DAYS gt3DAYS
    PREMATURE FULL TERM
  • Hypoxic-ischemic
  • encephalopathy
  • Intracranial
  • hemorrhage
  • Intracranial infection

  • Developmental
  • defects
  • Hypoglycemia
  • Hypocalcaemia
  • Other metabolic
  • Epileptic syndromes


32
  • Inborn Errors of Metabolism Associated With
    Neonatal Seizures
  • Conditions That Have a Specific Treatment
  • Pyridoxine (B6) dependency
  • Folinic acid-responsive seizures
  • Glucose transporter defect
  • Creatine deficiency
  • Other Conditions
  • Nonketotic hyperglycinemia
  • Sulfite oxidase deficiency
  • Molybdenum cofactor deficiency (combined
    deficiency)
  • Carbohydrate-deficient glycoprotein disorder
  • Lactic acid disorders
  • Mitochondrial disorders
  • Maple syrup urine disease
  • Isovaleric acidemia (sweaty feet, cheesy odor)

33
  • Inborn Errors of Metabolism Associated With
    Neonatal Seizures
  • Other conditions
  • Isovaleric acidemia (sweaty feet, cheesy odor)
  • 3-methylcrotonyl-CoA carbosylase deficiency
  • Propionic acidemia
  • Mevalonic aciduria
  • Urea cycle defects
  • Hyperornithemia-Hyperammonemia-Homocitrullinuria
    (HHH) syndrome
  • Neonatal glutaric aciduria type ll
  • Biotin deficiencies, holocarboxylase synthetase
    deficiency
  • Fructose 1,6-diphosphatase deficiency
  • Hereditary Fructose intolerance
  • Menkes disease (trichopoliodystrophy
  • Peroxisomal disorders

NeoReviews vol.5 no.6 June 2004
34
Laboratory Studies to Evaluate Neonatal Seizures
  • Indicated
  • Complete blood count, differential, platelet
    count urinalysis
  • Blood glucose (Dextrostix), BUN, Ca, P, Mg,
    electrolytes
  • Blood oxygen and acid-base analysis
  • Blood, CSF and other bacterial cultures
  • CSF analysis
  • EEG

35
Laboratory Studies to Evaluate Neonatal Seizures
  • Clinical Suspicion of Specific Disease
  • Serum immunoglobulins, TORCH antibody titers, and
    viral cultures
  • Blood and urine metabolic studies
    (bilirubin,ammonia, lactate, FECl³, reducing
    substance.)
  • Blood and urine toxic screen
  • Blood and urine amino and organic acid screen
  • CT or ultrasound scan

36
  • Metabolic Evaluation for Refractory Neonatal
    Seizures
  • Consider individually by case specifics
  • Serum
  • Glucose
  • Electrolytes (sodium, potassium, chloride, carbon
    dioxide), blood urea nitrogen, chromium, calcium,
    phosphorus, magnesium
  • Uric acid
  • Creative kinase
  • Serum ammonia
  • Lactic and pyruvic acids
  • Biotinidase
  • Amino acids
  • Serum carnitine, acylcarnitines
  • Serum transferrin
  • Copper and ceruloplasmin
  • Cholesterol
  • Fatty acids (short-chain, medium-chain,
    long-chain)
  • Pipecolic acid

NeoReviews vol.5 no.6 June 2004
37
  • Metabolic Evaluation for Refractory Neonatal
    Seizures
  • Urine
  • Organic acids
  • Acylglycines
  • Uric acid
  • Sulfites
  • Xanthine, hypoxanthine
  • Guanidinoacetate
  • Pipecolic acid
  • Cerebrospinal Fluid
  • Cell count, glucose,protein
  • Lactic and pyruvic acids
  • Amino acids
  • Organic acids
  • Neurotransmitters
  • Other Studies
  • Skin biopsy
  • Muscle biopsy
  • Magnetic resonance imaging with magnetic
    resonance spectroscopy (especially for creatine)

38
Treatment
  • Identify the underlying cause
  • hypoglycemia - D10 solution
  • hypocalcemia - Calcium gluconate
  • hypomagnesemia- Magnesium sulfate
  • pyridoxine deficiency- Pyridoxine
  • meningitis- initiation of antibiotics

39
Treatment
  • To minimize brain damage
  • Some controversy when to start
  • anticonvulsants
  • If seizure is prolonged (longer than 3
  • minutes), frequent or associated
  • with cardiorespiratory disturbance

40
  • Drug Therapy For Neonatal Seizures
  • Standard Therapy
  • AED Initial Dose
    Maintenance Dose Route
  • Phenobarbital 20mg/kg 3 to 4
    mg/kg per day lV, lM, PO
  • Phenytoin 20 mg/kg 3 to
    4 mg/kg per day lV, POª
  • Fosphenytoin 20 mg/kg phenytoin 3 to 4
    mg/kg per day lV, lM
  • equivalents
  • Lorazepam² 0.05 to 0.1 mg/kg Every 8
    to 12 hours lV
  • Diazepam² 0.25 mg/kg
    Every 6 to 8 hours lV
  • AED andtiepileptic drug lV intravenous lM
    intramuscular PO oral
  • ªOral phenytoin is not well absorbed.
  • ²Benzodiazepines typically not used for
    maintenance therapy.
  • ³Lorazepam preferred over diazepam.

41
Acute therapy of neonatal seizures
  • If with hypoglycemia- Glucose 10 2ml/k IV
  • If no hypoglycemia- Phenobarbital20mg/k IV
  • loading dose
  • If necessary additional phenobarbital
  • 5 mg/kg IV to a max of 20 mg/kg
  • (consider omission of this additional
  • Phenobarbital
  • if with baby is asphyxiated)
  • Phenytoin 20 mg/kg, IV (1 mg/kg/min)
  • Lorazepam0.05-0.10 mg/kg, IV

42
Pharmacological properties of Phenobarbital
  • Enters the CSF/brain rapidly with high efficiency
  • The blood level is largely predictable from the
    dose administered
  • It can be given IM or IV(more preferred)
  • Maintenance therapy accomplished easily with oral
    therapy
  • Protein binding lower in newbornfree levels of
    drug are higher
  • Entrance to the brain increased by local acidosis
    associated with seizures

43
  • Alternative Antiepileptic Drugs (AED) for
    Neonatal Seizures
  • Intravenous AEDs
  • High-dose phenobarbital gt30 mg/kg
  • Pentobarbital 10 mg/kg, then 1 mg/kg per hour
  • Thiopental 10 mg/kg, then 2 to 4 mg/kg per hour
  • Midazolam 0.2 mg/kg, then 0.1 to 0.4 mg/kg per
    hour
  • Clonazepam 0.1 mg/kg
  • Lidocaine 2 mg/kg, then 6 mg/kg per hour
  • Valproic acid 10 to 25 mg/kg, then 20 mg/kg per
    day in 3 doses
  • Paraldehyde 200 mg/kg, then 16 mg/kg per hour
  • Chlormethiazole Initial infusion rate of 0.08
    mg/kg per minute
  • Dexamethasone 0.6 to 2.8 mg/kg
  • Pyridoxine (B6) 50 to 100 mg, then 100 mg every
    10 minutes (up to 500mg)

44
  • Alternative AEDs for Neonatal Seizures
  • Oral AEDs
  • Primidone 15 to 25 mg/kg per day in 3 doses
  • Clonazepam 0.1 mg/kg in 2 to 3 doses
  • Carbamazepine 10 mg/kg, then 15 to 20 mg/kg per
    day in 2 doses
  • Oxcarbamazepine no data on neonates, young
    infants
  • Valproic acid 10 to 25 mg/kg, then 20 mg/kg per
    day in 3 doses
  • Vigabatrin 50 mg/kg per day in 2 doses, up to
    200 mg/kg per day
  • Lamotrigine 12.5 mg in 2 doses
  • Topiramate 3 mg/kg per day
  • Zonisamide 2.5 mg/kg per day
  • Levetiracetam 10 mg/kg per day in 2 doses
  • Folinic acid 2.5 mg BID, up to 4 mg/kg per day

NeoReviews vol.5 no.6 June 2004
45
Determinants of Duration of anticonvulsant
therapy for neonatal seizures
  • Neonatal neurological examination
  • Cause of neonatal seizure
  • Electroencephalogram

46
Duration of anticonvulsant therapy-Guidelines
  • Neonatal period
  • If neonatal neurological examination becomes
    normal discontinue therapy
  • If neonatal neurological examination is
    persistently abnormal,consider etiology and
    obtain EEG
  • In most such cases- Continue phenobarbital
  • - Discontinue
    phenytoin
  • - Reevaluate in
    1 month

47
Duration of anticonvulsant therapy-Guidelines
  • One month after discharge
  • If neurological examination has become normal,
    discontinue phenobarbital
  • If neurological examination is persistently
    abnormal,obtain EEG
  • If no seizure activity on EEG, discontinue
    phenobarbital

48
Prognosis
  • Two most useful approaches in utilizing outcome
  • EEG
  • Recognition of the underlying neurological
    disease

49
Prognosis of Neonatal seizures in relation to EEG
  • EEG BACKGROUND NEUROLOGICAL SEQUELAE()
  • Normal ?10
  • Severe abnormalities ?90
  • Moderate abnormalities 50
  • Based primarily on data reported by Rowe JC,
    Holmes GL, Hafford J, et al
  • Electroencephalogr Clin Neurophysiol 60183-196,
    1985 Lombroso CT In
  • Wasterlain CG, Treeman DM, Porter R, editors
    Advances in neurology, New
  • York, 1983, Raven Press and includes both
    full-term and premature infants.
  • Burst-suppression pattern, marked voltage
    suppression, and electrocerebral
  • Silence.
  • Voltage asymmetries and immaturity.

50
  • Causes of Neonatal Seizures and Outcomes
  • Percent of
  • Patients Who
  • Have Normal
  • Cause Development
  • Hypoxic-ischemic encephalopathy 50
  • Intraventricular hemorrhage 10
  • Subarachnoid hemorrhage 90
  • Hypocalcemia
  • Early-onset 50
  • Later-onset 100
  • Hypoglycemia 50
  • Bacterial meningitis 50
  • Developmental malformations 0
  • Benign familial neonatal convulsions 100
  • Fifth-day fits 100

51
Complications
  • Cerebral palsy
  • Hydrocephalus
  • Epilepsy
  • Spasticity
  • Feeding difficulties

52
Consultations
  • Neurology consult needed for
  • - evaluation of seizures
  • - evaluation of EEG and video EEG
  • monitoring
  • - management of anticonvulsant
  • medications

53
Further Outpatient Care
  • Neurology outpatient evaluation
  • Developmental evaluation for early identification
    of physical or cognitive deficits
  • Orthopedic evaluations if with joint deformities
  • Consider physical medicine/physical therapy
    referral if indicated

54
References
  • 1.Volpe JJ.Neonatal seizures. InNeurology of the
    newborn.4th ed.Philadelphia,PaWB Saunders's
    Co2001178-214
  • 2.Hahn J,Olson D.Etiology of neonatal
    seizures.NeoReviews.20045327-335
  • 3.Riviello,J.Drug therapy for neonatal
    seizuresPart I.NeoReviews.20045215-220
  • 4.Riviello,J.Drug therapy for neonatal
    seizuresPart II.NeoReviews.20045262-268
  • 5.Fanaroff A,Martin R,Neonatal seizures.InNeonata
    l-Perinatal Medicine-Diseases of the fetus and
    infant.6th ed.St.Louis,MOMosby-Yearbook
    Inc.1997899-911
  • 6.Sheth R, Neonatal seizuresEmedicine.com

55

Thank You
Write a Comment
User Comments (0)
About PowerShow.com